When: Pullback to $900-$920 zone with RS vs SPY holding

Then: High-conviction add, stop $895

When: Confirmed close >$965-975 on >2M volume with MACD histogram expanding

Then: Trim 10-15% defensive slice into strength

When: Confirmed close <$906 on >2M volume with RSI <35

Then: Trim 25-30% of remaining toward defensive, reset stop to $880

HOLD

• COST has lagged the S&P 500 YTD, 12% off its 52-week high while the broader market is at records
• 48x trailing P/E and 42x forward P/E represent stretched valuations the market is already pricing
• The 91% membership renewal rate is the reason the stock is at 48x, not a catalyst for further upside
• The membership fee annuity value has already been capitalized by the market
• The aggressive analyst's half-position setup at $961 with $905 stop and $1,025 target delivers actual risk/reward of 1.1:1, not 1.6:1
• Medicare Advantage/SCAN partnership is a 'press release' not confirmed revenue, with 5 million enrollee TAM being theoretical, making it a 2027-2028 story at scale
• Q3 FY26 showed revenue +11.6% and EPS +15.2%, but these results are already priced into the 42x forward multiple
• A Fed pivot is required to justify the $1,025 target, but prediction markets show 8% recession probability and 85% probability of no rate cuts
• Technical setup is 'coiled and indecisive' with 200 SMA at $956, current price $961 ($5 premium), and moving averages clustered within 1.3% of each other
• If 200 SMA breaks, next support is lower Bollinger Band at $925, a 4% drop, with potential for 8-10% in worsening macro conditions
• Recommended strategy: wait for pullback to $905-$925 for a confirmed risk/reward of more than 2:1 with 0% drawdown risk

→ vs aggressive: The 'wrong framework' criticism is invalid—the market uses P/E multiples to price all equities and is currently voting 'expensive is expensive' by not buying COST at 48x trailing and 42x forward P/E

→ vs aggressive: The defensive rotation narrative is not happening in the data—COST is 12% off its 52-week high while the market is at records

→ vs aggressive: The membership fee annuity argument 'cuts the wrong way'—it explains current valuation, not future upside; the analyst is 'double-counting' by using it as both justification and catalyst

→ vs aggressive: The half-position framework is not conservative—it is a 6% drawdown risk with 6.7% upside target, which is 'a coin flip with fees,' not a 1.6:1 risk/reward setup

→ vs aggressive: The Medicare Advantage catalyst is 'the most overplayed piece'—it is a 'press release' with 5 million enrollee TAM being theoretical, making it a 2027-2028 story at scale, not a near-term catalyst

→ vs aggressive: The Q3 FY26 results are 'already priced' by the 42x forward multiple, and the Fed pivot required for the bull case 'contradicts' what macro prediction markets are pricing (85% no rate cuts)

→ vs aggressive: The technicals are 'inconclusive,' not 'aligned'—the stock is RECLAIMING the 200 SMA ($956) from below at only a $5 premium ($961), and moving averages are clustered within 1.3%, indicating a coiled, indecisive setup rather than a confirmed uptrend

HOLD – maintain current exposure; consider starter position on shallow pullback to $948–$954; do not initiate at $961 or chase to $975+

• Membership fee annuity justifies current 48x trailing earnings but cannot simultaneously justify further upside—aggressive analyst is double-counting the same feature
• Technical setup is coiled and indecisive, not a confirmed breakout; stock is 5 dollars above 200-day MA and 12% off 52-week high
• Medicare Advantage catalyst with SCAN Group (5 million Medicare enrollees) is structurally meaningful but a 2027–2028 story, not a Q4 FY26 driver
• Aggressive analyst's risk-reward calculation is incorrect: entry $961, stop $905, target $1025 yields 1.15:1, not the claimed 1.6:1
• Conservative analyst's defensive rotation argument is flawed—COST lagging YTD does not prove rotation isn't occurring
• Conservative analyst's $905–$925 entry zone is conditional on macro deterioration that may not arrive, and in that scenario multiple compression risk rises
• Higher-for-longer rates are a mixed headwind: headwind for multiple but tailwind for business via resilient consumer spending
• Tiered entry approach recommended: starter position at $948–$954 (50 SMA and 10 EMA confluence); $950 entry with $905 stop yields 4.7:1 risk-reward to $1025 target
• Mental stop at $935 (approximately 1.4 ATRs below entry, aligning with lower Bollinger Band); close below $935 on volume signals technical breakdown
• Q4 FY26 earnings in September is the next major catalyst decision point—confirmation of double-digit growth supports multiple, while disappointment could drive pullback to $905–$925

→ vs aggressive: Risk-reward math error: entry $961, stop $905 (risk $56 or 5.8%), target $1025 (reward $64 or 6.7%) yields 1.15:1, not the claimed 1.6:1

→ vs aggressive: Double-counting: using the membership fee annuity (91% renewal rate) to justify both current 48x valuation and further upside is intellectually inconsistent; the market has already capitalized the annuity value

→ vs aggressive: A 5.8% drawdown tolerance is inappropriate for a defensive consumer staple; the asset class is designed for lower volatility compounding, not momentum-style risk management

→ vs conservative: Defensive rotation logic is flawed: lagging YTD does not prove rotation isn't happening—COST may lag because it is expensive and receiving less bid than cheaper defensives, or rotation simply hasn't started yet

→ vs conservative: The $905–$925 entry zone is a conditional outcome dependent on macro deterioration; in that scenario, multiple compression risk means the stock could fall to $800, making $905 a potentially poor entry

→ vs conservative: Overclaims on macro being uniformly negative: higher-for-longer signals a soft-landing, resilient consumer, and non-recessionary economy, which supports Costco's comp sales and membership growth